25 results
F-1
EX-10.2
AUTL
Autolus Therapeutics plc
7 May 18
Registration statement (foreign)
4:45pm
responsibility, jurisdiction, and authority to approve the manufacture, use, importation, packaging, labelling, for the approval of devices or products used … ) [***] by delivery of the shipped goods to [***], in adequate packaging and [***], on the Delivery Date (“Delivery”).
(b) Each shipment of Miltenyi Products shall
F-1/A
EX-10.2
AUTL
Autolus Therapeutics plc
8 Jun 18
Registration statement (foreign) (amended)
6:25am
responsibility, jurisdiction, and authority to approve the manufacture, use, importation, packaging, labelling, for the approval of devices or products used … to [***], in adequate packaging and [***], on the Delivery Date (“Delivery”).
(b) Each shipment of Miltenyi Products shall be [***] on the agreed delivery date(s
F-1/A
EX-10.2
AUTL
Autolus Therapeutics plc
10 May 18
Registration statement (foreign) (amended)
5:19pm
responsibility, jurisdiction, and authority to approve the manufacture, use, importation, packaging, labelling, for the approval of devices or products used … of the shipped goods to [***], in adequate packaging and [***], on the Delivery Date (“Delivery”).
(b) Each shipment of Miltenyi Products shall
F-1/A
EX-1.1
AUTL
Autolus Therapeutics plc
8 Jun 18
Registration statement (foreign) (amended)
6:25am
of its business (including, but not limited to, the testing, development, registration, licensure, application approval, manufacture, packaging … for checking and packaging at least twenty-four hours prior to the Time of Delivery (as defined below) with respect thereto at the office of DTC or its
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, process development, statistical analysis, pre-clinical and Clinical Trials, packaging development, regulatory affairs, and the preparation, filing … , manufacturing, supplying, processing, compounding, filling, finishing, packing, packaging, labeling, leafleting, quality assurance, quality control testing
F-1
EX-1.1
h0ypn
8 Apr 19
Registration statement (foreign)
4:34pm
8-K
EX-1.1
tuxc5f
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
6-K
EX-1.1
hplp7xy
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
EX-1.1
8u3nltppg20vfdb837
24 Jan 20
Autolus Announces Proposed Public Offering in the United States
4:06pm
6-K
EX-1.1
3q5q7i3 g3rgvw3z0iy
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1.1
491yj8wlfko1 srrw8k
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
20-F
0yak5efe1a43vr mil
23 Nov 18
Annual report (foreign)
12:00am
6-K
EX-1
mxrxctwd9vpr8tivndh4
30 Jun 21
Annual Report and Accounts
6:05am
F-1/A
s104ea9hbjkct86l06bh
8 Jun 18
Registration statement (foreign) (amended)
6:25am
F-1/A
5e40ux
19 Jun 18
Registration statement (foreign) (amended)
8:05am
424B4
oqx byy484
22 Jun 18
Prospectus supplement with pricing info
4:02pm
F-1/A
66nlgg47xkcxv1ydo
10 May 18
Registration statement (foreign) (amended)
5:19pm